These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35698261)

  • 1. Hepatocellular carcinoma requiring liver transplantation in hereditary tyrosinemia type 1 despite nitisinone therapy and α1-fetoprotein normalization.
    Bhushan S; Noble C; Balouch F; Lewindon P; Lampe G; Hodgkinson P; McGill J; Ee L
    Pediatr Transplant; 2022 Nov; 26(7):e14334. PubMed ID: 35698261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma in tyrosinemia type 1 without clear increase of AFP.
    van Ginkel WG; Gouw AS; van der Jagt EJ; de Jong KP; Verkade HJ; van Spronsen FJ
    Pediatrics; 2015 Mar; 135(3):e749-52. PubMed ID: 25667247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of dynamic thiol/disulfide homeostasis in hereditary tyrosinemia type 1 patients.
    Aktuglu Zeybek AC; Kiykim E; Neselioglu S; Iscan HZ; Zubarioglu T; Cansever MS; Erel O
    Pediatr Res; 2022 Aug; 92(2):474-479. PubMed ID: 34628487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary tyrosinemia type 1 in Turkey: twenty year single-center experience.
    Zeybek AC; Kiykim E; Soyucen E; Cansever S; Altay S; Zubarioglu T; Erkan T; Aydin A
    Pediatr Int; 2015 Apr; 57(2):281-9. PubMed ID: 25223216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 1 tyrosinemia in Finland: a nationwide study.
    Äärelä L; Hiltunen P; Soini T; Vuorela N; Huhtala H; Nevalainen PI; Heikinheimo M; Kivelä L; Kurppa K
    Orphanet J Rare Dis; 2020 Oct; 15(1):281. PubMed ID: 33046095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver Transplantation: A Safe and Definitive Alternative to Lifelong Nitisinone for Tyrosinemia Type 1.
    Menon J; Shanmugam N; Valamparampil JJ; Hakeem A; Vij M; Jalan A; Reddy MS; Rela M
    Indian J Pediatr; 2022 May; 89(5):438-444. PubMed ID: 34398413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver Transplant for Children With Hepatocellular Carcinoma and Hereditary Tyrosinemia Type 1.
    Bahador A; Dehghani SM; Geramizadeh B; Nikeghbalian S; Bahador M; Malekhosseini SA; Kazemi K; Salahi H
    Exp Clin Transplant; 2015 Aug; 13(4):329-32. PubMed ID: 24679101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosinemia type I treated by NTBC: how does AFP predict liver cancer?
    Koelink CJ; van Hasselt P; van der Ploeg A; van den Heuvel-Eibrink MM; Wijburg FA; Bijleveld CM; van Spronsen FJ
    Mol Genet Metab; 2006 Dec; 89(4):310-5. PubMed ID: 17008115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late Development of Hepatocellular Carcinoma in Tyrosinemia Type 1 Despite Nitisinone (NTBC) Treatment.
    Almuqbil M; Knoll J; Chinsky JM
    J Pediatr Gastroenterol Nutr; 2020 Aug; 71(2):e73-e75. PubMed ID: 32141999
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lectin-reactive alpha-fetoprotein in tyrosinaemia type I].
    Baumann U; Duhme V; Knerr I; Pronicka E; Auth MK; Voit PT
    Klin Padiatr; 2005; 217(3):142-6. PubMed ID: 15858705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver Cancer in Tyrosinemia Type 1.
    van Ginkel WG; Pennings JP; van Spronsen FJ
    Adv Exp Med Biol; 2017; 959():101-109. PubMed ID: 28755188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Live donor liver transplantation for type 1 tyrosinemia: An analysis of 15 patients.
    Karaca CA; Yilmaz C; Farajov R; Iakobadze Z; Aydogdu S; Kilic M
    Pediatr Transplant; 2019 Sep; 23(6):e13498. PubMed ID: 31155831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma in hereditary tyrosinemia type I despite 2-(2 nitro-4-3 trifluoro- methylbenzoyl)-1, 3-cyclohexanedione treatment.
    van Spronsen FJ; Bijleveld CM; van Maldegem BT; Wijburg FA
    J Pediatr Gastroenterol Nutr; 2005 Jan; 40(1):90-3. PubMed ID: 15625434
    [No Abstract]   [Full Text] [Related]  

  • 14. Tyrosinemia type 1: metastatic hepatoblastoma with a favorable outcome.
    Nobili V; Jenkner A; Francalanci P; Castellano A; Holme E; Callea F; Dionisi-Vici C
    Pediatrics; 2010 Jul; 126(1):e235-8. PubMed ID: 20547648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCC prevalence and histopathological findings in liver explants of patients with hereditary tyrosinemia type 1.
    Seda Neto J; Leite KM; Porta A; Fonseca EA; Feier FH; Pugliese R; Miura IK; Chapchap P; Porta G
    Pediatr Blood Cancer; 2014 Sep; 61(9):1584-9. PubMed ID: 24852359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary Tyrosinemia Type 1 in Turkey.
    Aktuglu-Zeybek AC; Kiykim E; Cansever MS
    Adv Exp Med Biol; 2017; 959():157-172. PubMed ID: 28755194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical follow up of Chilean patients with tyrosinemia type 1 treated with 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-ciclohexanedione (NTBC)].
    Raimann E; Cornejo V; Arias C; Cabello JF; Castro G; Fernández E; de la Parra A
    Rev Med Chil; 2012 Feb; 140(2):169-75. PubMed ID: 22739945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of tyrosinemia type 1 disease in patients treated with nitisinone in Spain.
    Couce ML; Sánchez-Pintos P; Aldámiz-Echevarría L; Vitoria I; Navas V; Martín-Hernández E; García-Volpe C; Pintos G; Peña-Quintana L; Hernández T; Gil D; Sánchez-Valverde F; Bueno M; Roca I; López-Ruzafa E; Díaz-Fernández C
    Medicine (Baltimore); 2019 Sep; 98(39):e17303. PubMed ID: 31574857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience of nitisinone for the pharmacological treatment of hereditary tyrosinaemia type 1.
    Santra S; Baumann U
    Expert Opin Pharmacother; 2008 May; 9(7):1229-36. PubMed ID: 18422479
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.